ArticleEClinicalMedicine2025
Global transmission characteristics of mpox outbreaks: a systematic review and meta-analysis.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- An integrated review of monkeypox: from pathogen and epidemiology to diagnostics, control, and challenges.Emerging microbes & infections · 2026Review
- Plant-based production and characterization of monoclonal antibodies targeting extracellular enveloped proteins of the Mpox Virus.Biotechnology reports (Amsterdam, Netherlands) · 2026Article
- From clinical fluids to environmental matrices: quantitative monitoring of infectious monkeypox virus based on PMA-qPCR during the Guangdong outbreak.Tropical medicine and health · 2026Article
- Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection.Virologica Sinica · 2026Article
- Mpox outbreak preparedness and response capacity in Nigeria's Federal Capital Territory: a mixed-methods study.BMC public health · 2026Article
- Peri-Umbilicated Pseudopustules in Mpox.Oxford medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mpox is a zoonotic infectious disease caused by the mpox virus. It was first reported in humans in the Democratic Republic of the Congo in 1970. Since then, it has mainly been prevalent in Central and West Africa. Starting from 2022, the mpox epidemic has spread globally. The objective of this study was to obtain key transmission parameters of the mpox virus, providing evidence-based support for scientific prevention and control of the epidemic worldwide. Methods: We used "mpox" and "monkeypox" as the keywords to retrieve studies from PubMed, Web of Science, and Scopus databases up to February 2025. Four key transmission parameters-basic reproduction number (R0), effective reproduction number (Rt), incubation period, and serial interval were extracted. Fixed-effect or random-effect models were used to estimate the pooled parameters. Hartung-Knapp (HKSJ) confidence intervals was reported to reflect uncertainty under high heterogeneity. The protocol of this study has been registered in the PROSPERO database (CRD42022339404). Findings: The study screened 2910 articles and included 47 articles (covering 43,387 mpox patients) based on inclusion and exclusion criteria. The R0 of mpox was 2.13 (95% CI [HKSJ]: 1.63, 2.62), the Rt of mpox was 2.51 (95% CI [HKSJ]: 2.05, 2.97), the incubation period of mpox was 9.21 (95% CI [HKSJ]: 8.03, 10.39) days, and the serial interval of mpox was 12.00 (95% CI [HKSJ]: 8.01, 15.99) days. Subgroup analysis found no significant differences in incubation period, and serial interval between men who have sex with men (MSM) and the general population. However, the Rt in the general population (2.20, 95% CI [HKSJ]: 1.71, 2.70) was smaller than the Rt in the MSM (3.08, 95% CI [HKSJ]: 2.41, 3.76). Interpretation: Mpox is a threat to global public health that cannot be ignored. This study found that each person infected with the mpox virus transmitted it to two others, and the epidemic has continued to spread. Both the incubation period and the serial interval exceeded one week, which is relatively long and has increased the difficulty of prevention and control. It is recommended that in the future, early monitoring and early warning be strengthened for high-risk populations to prevent the risk of mpox transmission. Funding: This study was funded by the Youth Beijing Scholars Program (087), National Natural Science Foundation of China (72474005, 72122001), and China Primary Health Care Foundation (20250307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper. No payment was received by any of the co-authors for the preparation of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.